Results 181 to 190 of about 36,080 (282)
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease. [PDF]
Hemicker G +12 more
europepmc +1 more source
A graphical abstract recapping the different sources of dental, periodontal, and other oral‐derived mesenchymal stromal cells (MSCs) and their regenerative mechanisms and potentials. The review's article findings bridge fundamental biological science with translational advances, highlighting the significance of MSCs in craniofacial regenerative ...
Karim M. Fawzy El‐Sayed +6 more
wiley +1 more source
Huntington's Disease: A Case Report of a Patient With a Positive Family History. [PDF]
Nowakowski P +4 more
europepmc +1 more source
Talking therapies for anxiety and depression in people affected by dementia: A scoping meta‐review
Abstract Background Symptoms of anxiety and depression are common in people affected by dementia (people with dementia and family carers). There are many reviews of psychological interventions to reduce stress and distress in people with dementia and family carers, but little cross‐fertilisation with the evidence base underpinning NHS Talking Therapies
Georgina Charlesworth +2 more
wiley +1 more source
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease. [PDF]
Petrillo J +15 more
europepmc +1 more source
Sequential activation of individual caspases, and of alterations in Bcl‐2 proapoptotic signals in a mouse model of Huntington's disease [PDF]
Yu Zhang +7 more
openalex +1 more source
Abstract Objectives Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by a range of motor, cognitive, and psychiatric symptoms. Psychological symptoms can arise from being at risk for the disease and from its manifestation, necessitating psychological interventions to address the evolving burden, even before onset. This
Kasper F. Van der Zwaan +4 more
wiley +1 more source
A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse [PDF]
Vanita Chopra +9 more
openalex +1 more source

